Mesoblast (MESO) stock Forecast for 2022 – 2026
Last update: December 8, 2022 (12:00)Sector: Healthcare
The share price of Mesoblast Limited (MESO) now
50/200 Day Moving Average: $3.078 / $3.355
This figure corresponds to the average price over the previous 50/200 days. For Mesoblast stocks, the 50-day moving average is the support level today.
For Mesoblast stocks, the 200-day moving average is the resistance level today.
Are you interested in Mesoblast Limited stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Mesoblast stock price in 2023, 2024, 2025, 2026, 2027. How much will one Mesoblast share be worth in 2023 - 2027?
When should I take profit in Mesoblast stock? When should I record a loss on Mesoblast stock? What are analysts' forecasts for Mesoblast stock? What is the future of Mesoblast stock? We forecast Mesoblast stock performance using neural networks based on historical data on Mesoblast stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Mesoblast stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Mesoblast shares. This happens once a day.
Historical and forecast chart of Mesoblast stock
The chart below shows the historical price of Mesoblast stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Mesoblast stock price can be found in the table below.
Long-term forecasts by years.
Mesoblast daily forecast for a month
Mesoblast Daily Price Targets
Mesoblast Stock Forecast 12-10-2022.
Forecast target price for 12-10-2022: $3.30.
Positive dynamics for Mesoblast shares will prevail with possible volatility of 3.892%.
Pessimistic target level: 3.23
Optimistic target level: 3.36
Mesoblast Stock Forecast 12-11-2022.
Forecast target price for 12-11-2022: $3.35.
Positive dynamics for Mesoblast shares will prevail with possible volatility of 2.553%.
Pessimistic target level: 3.31
Optimistic target level: 3.40
Mesoblast Stock Forecast 12-12-2022.
Forecast target price for 12-12-2022: $3.34.
Negative dynamics for Mesoblast shares will prevail with possible volatility of 3.120%.
Pessimistic target level: 3.32
Optimistic target level: 3.43
Mesoblast Stock Forecast 12-13-2022.
Forecast target price for 12-13-2022: $3.38.
Positive dynamics for Mesoblast shares will prevail with possible volatility of 3.346%.
Pessimistic target level: 3.34
Optimistic target level: 3.46
Mesoblast Stock Forecast 12-14-2022.
Forecast target price for 12-14-2022: $3.39.
Positive dynamics for Mesoblast shares will prevail with possible volatility of 3.037%.
Pessimistic target level: 3.36
Optimistic target level: 3.47
Mesoblast Stock Forecast 12-15-2022.
Forecast target price for 12-15-2022: $3.46.
Positive dynamics for Mesoblast shares will prevail with possible volatility of 3.276%.
Pessimistic target level: 3.44
Optimistic target level: 3.55
MESO (MESO) Monthly Stock Prediction for 2023
Mesoblast forecast for this year
Mesoblast Stock Prediction for Jan 2023
An uptrend is forecast for this month with an optimal target price of $3.98195. Pessimistic: $3.89. Optimistic: $4.27
Mesoblast Stock Prediction for Feb 2023
An uptrend is forecast for this month with an optimal target price of $4.34431. Pessimistic: $4.15. Optimistic: $4.54
Mesoblast Stock Prediction for Mar 2023
An downtrend is forecast for this month with an optimal target price of $4.1966. Pessimistic: $3.88. Optimistic: $4.36
Mesoblast Stock Prediction for Apr 2023
An uptrend is forecast for this month with an optimal target price of $4.25116. Pessimistic: $4.15. Optimistic: $4.49
Mesoblast Stock Prediction for May 2023
An downtrend is forecast for this month with an optimal target price of $4.11937. Pessimistic: $3.86. Optimistic: $4.25
Mesoblast Stock Prediction for Jun 2023
An downtrend is forecast for this month with an optimal target price of $4.00815. Pessimistic: $3.92. Optimistic: $4.29
Mesoblast Stock Prediction for Jul 2023
An uptrend is forecast for this month with an optimal target price of $4.16447. Pessimistic: $4.01. Optimistic: $4.46
Mesoblast Stock Prediction for Aug 2023
An downtrend is forecast for this month with an optimal target price of $4.05203. Pessimistic: $3.80. Optimistic: $4.27
Mesoblast Stock Prediction for Sep 2023
An downtrend is forecast for this month with an optimal target price of $3.94262. Pessimistic: $3.83. Optimistic: $4.19
Mesoblast Stock Prediction for Oct 2023
An uptrend is forecast for this month with an optimal target price of $4.32111. Pessimistic: $4.02. Optimistic: $4.60
Mesoblast Stock Prediction for Nov 2023
An downtrend is forecast for this month with an optimal target price of $4.00135. Pessimistic: $3.87. Optimistic: $4.16
Mesoblast Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $4.04536. Pessimistic: $3.95. Optimistic: $4.24
Mesoblast (MESO) Monthly Stock Prediction for 2024
Mesoblast (MESO) Monthly Stock Prediction for 2025
Mesoblast (MESO) Monthly Stock Prediction for 2026
Mesoblast (MESO) Monthly Stock Prediction for 2027
Mesoblast information and performance
The biopharmaceutical company Mesoblast Limited develops and markets allogeneic cellular medicines. The company offers products for the treatment of cardiovascular diseases, orthopedic diseases of the spine, oncology, hematology, as well as for immune-mediated and inflammatory diseases. Its patented regenerative medicine technology platform is based on specialized cells known as adult stem cells of mesenchymal origin.
LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AU
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.